We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Pharmacy/Global research trends on drug interactions with direct oral anticoagulants: A comprehensive bibliometric analysis. Article ofJournal of Applied Pharmaceutical Science Vol. 15(09), pp 052-073, September, 2025 .
ThesesPharmacy

Global research trends on drug interactions with direct oral anticoagulants: A comprehensive bibliometric analysis. Article ofJournal of Applied Pharmaceutical Science Vol. 15(09), pp 052-073, September, 2025 .

2025

Checking your access to this record.

Abstract & Overview

This study presents a bibliometric analysis of global research on drug interactions involving direct oral anticoagulants (DOACs), mapping field development, identifying hotspots, and highlighting trends to guide future studies and improve clinical safety. Effective management of DOAC interactions is critical in clinical and public health. Publications on DOAC interactions from 2011 to 2023 were retrieved from Scopus and analyzed using VOSviewer, Google Colab, and the R package bibliometrix, enabling performance assessment and science mapping. Analysis of 345 publications from 45 countries reveals a significant rise in DOAC research, led by contributions from North America, Europe, and East Asia, with the United States, Germany, and Japan producing the most publications. Notable institutions include Inserm, Harvard Medical School, and McMaster University, alongside industry leaders such as Daiichi Sankyo, Bayer AG, and Boehringer Ingelheim, underscoring academia-industry partnerships. Keyword analysis shows that key research themes identified are “Anticoagulant,” “Rivaroxaban,” “Atrial fibrillation,” and “Drug interaction.” Recent studies focus on physiologically based pharmacokinetic (PBPK) modeling and interactions within oncology and COVID-19 treatment, highlighting challenges in managing drug–drug interactions (DDIs) in polypharmacy. This analysis uncovers how pharmacokinetic and pharmacodynamic interactions contribute to improving the safety of DOACs, offering insights that can guide clinical approaches and formulate public health policies.

Cite this record

Henao-Torres Ivan, Álviz-Amador Antistio, Gómez-Sánchez Nathalie (2025). Global research trends on drug interactions with direct oral anticoagulants: A comprehensive bibliometric analysis. Article ofJournal of Applied Pharmaceutical Science Vol. 15(09), pp 052-073, September, 2025. https://library.shubhaarti.com/content/22b19b0b-fa49-4579-a6b6-4e908122b322

Copy in another style

Ivan, H., Antistio, Á., & Nathalie, G. (2025). Global research trends on drug interactions with direct oral anticoagulants: A comprehensive bibliometric analysis. Article ofJournal of Applied Pharmaceutical Science Vol. 15(09), pp 052-073, September, 2025 . https://library.shubhaarti.com/content/22b19b0b-fa49-4579-a6b6-4e908122b322
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.